Mikkel Ingstrup has a diverse work experience spanning multiple roles and industries. Currently, they serve as the Chief Executive Officer at Ably Medical since 2022. Prior to that, they held the position of Chief Technology Officer at Ably Medical from 2022 to 2023.
Before joining Ably Medical, Ingstrup worked at Prevas A/S for several years. Their roles at Prevas A/S include Engineering Manager from 2014 to 2022, where they were responsible for growing and managing the engineering department. Mikkel also served as a Program Manager from 2012 to 2014, focusing on international corporation and offshore development.
Ingstrup's earlier experience includes working as a Project Manager at Prevas A/S from 2008 to 2012, where they handled project management, sales, and contract negotiation. Prior to that, they worked at Infineon Technologies Denmark A/S as a Verification Manager and SW Designer, managing test and verification efforts and software development.
At the beginning of their career, Ingstrup worked as a Student at Thrane & Thrane A/S and as an Intern at Siemens ICM LLC.
Mikkel Ingstrup obtained a Diplom i Ledelse (Diploma in Management) from Erhvervsakademi Aarhus | Business Academy Aarhus, where they studied from 2018 to 2020. Prior to that, they pursued a Master of Science (M.Sc.) in Biomedical Engineering at Aarhus University between 2002 and 2004. Their undergraduate education includes a Bachelor of Science (B.Sc.) in Electronic Engineering from Engineering College of Aarhus, which they completed from 1999 to 2002.
March, 2023 - present
December, 2022